Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.

This year marks a record-breaking celebration of San Antonio’s favorite local businesses, thanks to your incredible participation. At MySA and the San Antonio Express-News, we’re proud to ...

Real-time index price for S&P Midcap 400 (IDX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Thousands celebrate the rapid results of weight loss injections. But a new analysis reveals a harsh truth few are prepared ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

The usual dose of Novo Nordisk’s expensive weight-loss drug Wegovy can be cut in half without affecting the results, ...